Bafna Pharma Live Share Price Today, Share Analysis and Chart

Name: Bafna Pharmaceuticals Ltd.: Is Infosys Ltd. worth buying?
Item: Bafna Pharmaceuticals Ltd.
Rating: 2.915708375
Author: Trendlyne DVM scores

Mid-range Performer

Iran war impact

Based on the review of the company's latest annual reports and financial results, the impact of the Iran-Israel war on Bafna Pharmaceuticals Ltd. is outlined below: ### Impact Assessment: Neutral to Low Bafna Pharmaceuticals has a **neutral t...

120.50 5.73 (4.99%)

40.36% Fall from 52W High

16,420

NSE+BSE Volume

High volume today

NSE 19 Mar, 2026 3:31 PM (IST)

Loading... You have run out of DVM views!

Subscribe now to see details

High Financial Strength

- / 100

Mid Valuation

- / 100

Technically Neutral

44.1 / 100

Mid-range Performer These stocks have strong quality. Their reasonable financials and technicals make them potentially attractive to investors View Similar Embed DVM

No estimates available

Bafna Pharma Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Is Bafna Pharmaceuticals Ltd. worth buying?

25 Votes:

Buy 68.0%

Sell 24.0%

Hold 8.0%

Bafna Pharma Live Share Price Today, Share Analysis and Chart

Based on the review of the company's latest annual reports and financial results, the impact of the Iran-Israel war on Bafna Pharmaceuticals Ltd. is outlined below: ### Impact Assessment: Neutral to Low Bafna Pharmaceuticals has a **neutral t...

40.36% Fall from 52W High

High volume today

SWOT Analysis

Bafna Pharma Live Price Chart